A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus the Combination of Emtricitabine and Tenofovir DF for the Treatment of Chronic Hepatitis B
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Emtricitabine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 28 Apr 2013 Results presented at the 48th Annual Meeting of the European Association for the Study of the Liver.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00507507).
- 08 Jul 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12607000371493).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History